Making her introduction to the world with a rare Inauguration Day appearance, new White House Press Secretary Jen Psaki (SOCK-eee) vowed to “share the truth,…
[Read More]
Are You Getting Paid for the Risks You’re Taking?
Even when most stocks are rising, some do better than others, and some are riskier than others. Make sure you earn what you deserve for…
[Read More]
Gene Therapy Shows Promise But Still Has A Ways to Go
Gene therapy has the potential to be a game-changing therapeutics to correct genetic “errors” that can cause rare diseases and illnesses. By replacing a mutated…
[Read More]
If the Future is Female, Women Need to Invest in It Now
In 2020, the gender pay gap found that women earned 81 cents for every dollar a man made, according to PayScale, and the year was…
[Read More]
Earnings Season begins with Covid Numbers Still Rising
The Oxford primary definition of the word “conundrum” is “a confusing and difficult problem or question.” Most of us are familiar with this. Less popular…
[Read More]
How the Pandemic Changed How We Invest
The coronavirus pandemic transformed nearly every part of our lives in 2020, from social interactions to work, travel, education and politics. We watched as schools…
[Read More]
3 Micro-cap E-Commerce Stocks For 2021
E-commerce has been a high-growth industry for several years, but the pandemic has helped advance digital commerce years into the future. As consumers adapt to…
[Read More]
Will SEC Suit over XRP affect Crypto Investments in 2021?
Trust and uncertainty are opposite sides of the same coin. Each of them is a market mover. With cryptocurrency, the trust factor has been hard-earned…
[Read More]
3 Smallcaps to Upgrade U.S. Capitol Security
On January 6, 2021, the world watched as the unthinkable happened: an angry mob mobilized and stormed the United States Capitol. For historical context, the…
[Read More]
How Will You Spend Your Next Stimulus Check?
Although they are less than the $2,000 many were hoping for, the current round of stimulus checks still offer a $600 jolt to help recipients…
[Read More]
Investors Prism 2020: A Year in Review
As the calendar turns to 2021, Investors Prism looks back at its first year. In January 2020, Investors Prism officially launched its seven initial indices…
[Read More]
Top 3 Outperformers of the PRISM Emerging Vaccines & Cell Therapy Index
The coronavirus pandemic has made vaccines a major theme for 2020. As the virus began to spread throughout the globe in early 2020, the scientific…
[Read More]